Aclarion ACON Crushes Q1 2026 Estimates EPS 134 Tops Views AN2 Thera ANTX Q1 2026 Earnings Miss EPS 029 vs 023 Expected Delhivery Q4FY26 Net Profit Nearly Flat at 724 Crore Despite 30 Revenue Surge Biotech and Pharma Stocks Slide as Capital Rotates Toward Energy Sector Cytokinetics CYTK Edges Higher as Shares Test Key Resistance Zone DMII Drugs Made In America Acquisition II Corp Hovers Near Resistance as Trading Volume Remains Subdued Elanco Animal Health ELAN Gains 192 as Shares Approach Key Resistance ServiceNow NOW Lifts Above 102 Bullish Momentum Gains Steam